0001104659-23-112563.txt : 20231030 0001104659-23-112563.hdr.sgml : 20231030 20231030160853 ACCESSION NUMBER: 0001104659-23-112563 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231026 FILED AS OF DATE: 20231030 DATE AS OF CHANGE: 20231030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooper Joseph Patrick CENTRAL INDEX KEY: 0001368711 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37846 FILM NUMBER: 231360285 MAIL ADDRESS: STREET 1: PETER TSOFLIAS, C/O BLANK ROME LLP STREET 2: ONE LOGAN SQUARE, FL 9 CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quoin Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001671502 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 BUSINESS ADDRESS: STREET 1: 23 HATA'AS STREET CITY: KFAR SABA STATE: L3 ZIP: 44425 BUSINESS PHONE: 97299741444 MAIL ADDRESS: STREET 1: 23 HATA'AS STREET CITY: KFAR SABA STATE: L3 ZIP: 44425 FORMER COMPANY: FORMER CONFORMED NAME: Cellect Biotechnology Ltd. DATE OF NAME CHANGE: 20160721 FORMER COMPANY: FORMER CONFORMED NAME: Cellect Biomed Ltd. DATE OF NAME CHANGE: 20160406 4 1 tm2329341-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-10-26 0 0001671502 Quoin Pharmaceuticals, Ltd. QNRX 0001368711 Cooper Joseph Patrick C/O QUOIN PHARMACEUTICALS LTD. 42127 PLEASANT FOREST COURT ASHBURN VA 20148 1 0 0 0 0 Share Option (Right to Buy) 5.75 2023-10-26 4 A 0 7652 0 A 2024-10-26 2033-10-26 American Depositary Share 7652 7652 D The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS. The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027. /s/ Joseph Cooper 2023-10-30